Food and Drug Administration (FDA) approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related condition, such as high blood pressure or type 2 diabetes
Wilding JPH, Kwan AYM, Maldonado JM, Wang H, Rasouli N (2022) Tirzepatide induces weight loss in patients with type 2 diabetes regardless of baseline BMI: a post hoc analysis of SURPASS-1 through SURPASS-5 studies
- You are over the age of 50, as the ability to absorb B12 decreases with age
Common Signs and Symptoms Lack of strength in muscles Persistent weariness and fatigue Low levels of sugar in the blood Heart or liver complications in extreme cases The signs and symptoms of carnitine deficiency depend on the gravity of the case and the underlying reason
Schedule an Appointment to Learn More If youre interested in learning more about how GLP-1/GIP receptor agonists can help you achieve your weight loss and health goals, schedule an appointment with Boise Natural Health Clinic today
It is sometimes, but not always, associated with food consumption